Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritis

European Cytokine Network

Volumn 18, Issue 3, 2007, Pages 127-135

  González, Carlos ^a   Abello, Paula ^b   Cepeda, Raquel ^a   Salazar, Lorena ^c   Aravena, Octavio ^b   Pesce, Barbara ^b   Catalán, Diego ^b   Aguillón, Juan C ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c NONE   (Chile)

Author keywords

Angiogenesis; Apoptosis; Arthritis; CIA; Morphometric analysis

Indexed keywords

COLLAGEN TYPE 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSIS; APOPTOSIS; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MORPHOMETRICS; MOUSE; NONHUMAN; SYNOVIUM; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; CATTLE; CHONDROCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; JOINTS; MICE; MICE, INBRED DBA; NEOVASCULARIZATION, PATHOLOGIC; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; SYNOVITIS; VON WILLEBRAND FACTOR;

BOVINAE; MURINAE; MUS;

EID: 35348873727     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2007.0099     Document Type: Article

References (40)

1. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002; 4: S81.
2. Weyand C, Goronzy J. The molecular basis of rheumatoid arthritis. J Mol Med 1997; 75: 772.
3. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358: 903.
4. Feldman M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397.
5. Rosloniec EF, Brand DD, Myers LK, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997; 185: 1113.
6. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003; 25: 3.
7. Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchel T, Feldman M. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage - pannus junction in patients with rheumatoid arthritis: Implications for local actions of tumor necrosis factor α. Arthritis Rheum 1998; 32: 1170.
8. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1 associated protein TRADD signals cell death and NF-κB activation. Cell 1995; 81: 495.
9. Bai S, Liu H, Chen KH, Eksarko P, Perlman H, Moore TL, Pope RM. NF-κB- regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor α-mediated apoptosis. Arthritis Rheum 2004; 50: 3844.
10. Yatsugi N, Tzukazaki T, Osaki N, Koji T, Yamashita S, Shindo H. Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: Correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related protein p53 and c-myc. J Orthop Sci 2000; 5: 150.
11. Macnaul KL, Hutchinson NI, Parsons JN, Bayne EK, Tocci MJ. Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J Immunol 1990; 145: 4154.
12. Colville-Nash PR, Scout DL. Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implications. Ann Rheum Dis 1992; 51: 919.
13. Walsh DA. Angiogenesis and arthritis. Rheumatol 1999; 38: 103.
14. Koch AE. Angiogenesis as target in rheumatoid arthritis. Ann Rheum Dis 2003; 62: 60.
15. Clavel G, Valvason C, Yamaoka K, et al. Relationship between angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw 2006; 17: 1.
16. Clavel G, Bessis N, Boissier MC. Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003; 70: 321.
17. Paleolog EM, Young S, Stark AC, et al. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor-a and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1258.
18. Nagashima M, Asano G, Yoshino S. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J Rheumatol 2000; 27: 2339.
19. Fava RA, Olsen NJ, Spencer-Green G, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180: 341.
20. Maeno N, Takei S, Imanaka H, et al. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol 1999; 10: 2244.
21. Lu J, Kasama T, Kobayashi K, et al. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 2000; 164: 5922.
22. Sone H, Kawakami Y, Sakauchi M, et al. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 2001; 281: 562.
23. Sekimoto T, Hamada K, Oike Y, et al. Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein. J Rheumatol 2002; 29: 240.
24. Miotla J, Maciewicz R, Kendrew J, et al. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000; 80: 1195.
25. Hashimoto S, Ochs RL, Rosen F, et al. Chondrocyte derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 1998; 95: 3094.
26. Blanco FJ, Guitian R, Vazquez-Martul E, et al. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Artritis Rheum 1998; 41: 284.
27. Courtenay JS, Dallman MJ, Dayan AD, et al. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666.
28. Yuasa T, Kubo S, Yoshino T, et al. Deletion of Fcgamma receptor IIb renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999; 189: 187.
29. Jou IM, Shiau AL, Chen SY, et al. Thrombospondin 1 as an effective gene therapeutic strategy in collagen induced arthritis. Arthritis Rheum 2005; 52: 339.
30. Steel RGD, Torrie JH. Principles and procedures of statistics: A biometral approach. Mc Graw-Hill, New York: México, 1980.
31. StataCorp. STATA Statistical Software: Release 5.0. College Station, TX: Stata Corporation. U.S.A., 1997.
32. De Bandt M, Ben Mahdi MH, Ollivier V, et al. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol 2003; 171: 4853.
33. Takeshita M, Hinoue H, Furukawa O, et al. Initial arthritic lesions induced by immunization with type II collagen in Lewis rats. Exp Anim 1995; 44: 63.
34. Van't Hof RJ, Hocking L, Wright PK, et al. Nitric oxide is a mediator of apoptosis in the rheumatoid joint. Rheumatol 2000; 39: 1004.
35. Schmitt-Sody M, Landes J, Zysk SP, et al. Quantitative assessment of angiogenesis in murine antigen-induced arthritis by intravital fluorescence microscopy. J Vasc Res 2003; 40: 460.
36. Larsson E, Muèssener A, Heinegaê D, et al. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Rheumatol 1997; 36: 1258.
37. Tak PP, Klapwijk MS, Broersen SF, et al. Apoptosis and p53 expression in rat adjuvant arthritis. Arthritis Res 2000; 2: 229.
38. Kim HA, Lee YJ, Seong SH, et al. Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 2000; 27: 455.
39. Lots M, Hashimoto S, Kühn K. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 1999; 7: 389.
40. Spears R, Oakes R, Bellinger LL, et al. Tumor necrosis factor-alpha and apoptosis in the rat temporomandibular joint. Arch Oral Biol 2003; 48: 825.